Host: |
Goat |
Applications: |
Pep-ELISA/WB/IHC |
Reactivity: |
Human/Mouse/Cow |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-Ascl3-Mouse (Internal) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
WB-0.1-0.3µg/mlIHC-3.75µg/mlELISA-antibody detection limit dilution 1:8000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
ASCL3 |
Gene ID: |
56676 |
Uniprot ID: |
ASCL3_HUMAN |
Immunogen Region: |
Internal |
Accession Number: |
NP_064435.1 |
Immunogen Sequence: |
HLPEDYLEKRLSK |
Function | Transcriptional repressor. Inhibits myogenesis. Plays a role in progenitor cells which differentiate into ductal and acinar, but not myoepithelial, cell lineages in the salivary glands. Involved in the functions of the microvillar cells and Bowman's glands and probably, in a non-cell-autonomous manner, in the development or regeneration of a complete olfactory epithelium (OE). |
Protein Name | Achaete-Scute Homolog 3Ash-3Hash3Class A Basic Helix-Loop-Helix Protein 42Bhlha42Bhlh Transcriptional Regulator Sgn-1 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Achaete-Scute Homolog 3 antibodyAnti-Ash-3 antibodyAnti-Hash3 antibodyAnti-Class A Basic Helix-Loop-Helix Protein 42 antibodyAnti-Bhlha42 antibodyAnti-Bhlh Transcriptional Regulator Sgn-1 antibodyAnti-ASCL3 antibodyAnti-BHLHA42 antibodyAnti-HASH3 antibodyAnti-SGN1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance